Tag: Pathos AI AstraZeneca deal
Pathos AI Expands Oncology Pipeline Through Strategic Deals with Alphamab and AstraZeneca
Pathos AI announced two separate licensing and co-development agreements with Alphamab Oncology and AstraZeneca, expanding its clinical-stage pipeline of targeted cancer therapies using its proprietary platform,...